1. Shp2 expression is upregulated in cervical cancer, and Shp2 contributes to cell growth and migration and reduces sensitivity to cisplatin in cervical cancer cells
   Meng Cao et al, 2019, Pathology - Research and Practice CrossRef
2. Scrutinizing the therapeutic and diagnostic potential of nanotechnology in thyroid cancer: Edifying drug targeting by nano-oncotherapeutics
   Esraa Ghazy et al, 2021, Journal of Drug Delivery Science and Technology CrossRef
3. SHP2 phosphatase as a novel therapeutic target for melanoma treatment
   Ruo-Yu Zhang et al, 2016, Oncotarget CrossRef
4. Stepping out of the shadows: Oncogenic and tumor-promoting protein tyrosine phosphatases
   Ari Elson, 2018, The International Journal of Biochemistry & Cell Biology CrossRef
5. PTPN11 Knockdown Prevents Changes in the Expression of Genes Controlling Cell Cycle, Chemotherapy Resistance, and Oncogene-Induced Senescence in Human Thyroid Cells Overexpressing BRAF V600E Oncogenic Protein
   L. V. Putlyaeva et al, 2020, Biochemistry (Moscow) CrossRef
6. The Mechanism of CagA and VacA in Gastric Cancer under the Tumor Microenvironment and Vitro Factors
   Zhu Jiang Dai et al, 2020, Journal of Nutritional Oncology CrossRef
7. Tyrosine phosphatase PTPN11/SHP2 in solid tumors - bull’s eye for targeted therapy?
   Xun Chen et al, 2024, Frontiers in Immunology CrossRef
8. Next-Generation Molecular Imaging of Thyroid Cancer
   Yuchen Jin et al, 2021, Cancers CrossRef
9. LNDriver: identifying driver genes by integrating mutation and expression data based on gene-gene interaction network
   Pi-Jing Wei et al, 2016, BMC Bioinformatics CrossRef
10. Clinicopathological and prognostic significance of SHP2 and Hook1 expression in patients with thyroid carcinoma
    Jun Cao et al, 2018, Human Pathology CrossRef
11. High expression of SHP2 predicts a promising prognosis in colorectal cancer
    Xibo Liu et al, 2024, Indian Journal of Pathology and Microbiology CrossRef
12. Oncogenic Tyrosine Phosphatases: Novel Therapeutic Targets for Melanoma Treatment
    Elisa Pardella et al, 2020, Cancers CrossRef
13. Follicular Thyroid Adenoma and Follicular Thyroid Carcinoma—A Common or Distinct Background? Loss of Heterozygosity in Comprehensive Microarray Study
    Martyna Borowczyk et al, 2023, Cancers CrossRef
14. Thyroid Cancer Detection by Ultrasound Molecular Imaging with SHP2-Targeted Perfluorocarbon Nanoparticles
    ZhongQian Hu et al, 2018, Contrast Media & Molecular Imaging CrossRef
15. Nanomaterials: a promising multimodal theranostics platform for thyroid cancer
    Lei Li et al, 2023, Journal of Materials Chemistry B CrossRef
16. PD-1 blockade delays tumor growth by inhibiting an intrinsic SHP2/Ras/MAPK signalling in thyroid cancer cells
    Federica Liotti et al, 2021, Journal of Experimental & Clinical Cancer Research CrossRef
17. Integrating omics data and protein interaction networks to prioritize driver genes in cancer
    Tiejun Zhang et al, 2017, Oncotarget CrossRef